News stories about Exponent (NASDAQ:EXPO) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Exponent earned a daily sentiment score of 0.03 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 47.219860820297 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

These are some of the media stories that may have effected Accern’s scoring:

A number of brokerages have recently issued reports on EXPO. ValuEngine raised Exponent from a “sell” rating to a “hold” rating in a research report on Thursday, July 20th. Zacks Investment Research raised Exponent from a “hold” rating to a “buy” rating and set a $74.00 target price on the stock in a research report on Thursday, July 20th. BidaskClub lowered Exponent from a “hold” rating to a “sell” rating in a research report on Tuesday, June 20th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $75.00 target price (up from $69.00) on shares of Exponent in a research report on Wednesday, July 19th.

Shares of Exponent (EXPO) traded up 0.09% during midday trading on Wednesday, hitting $65.95. The stock had a trading volume of 43,820 shares. Exponent has a 52 week low of $48.42 and a 52 week high of $68.30. The stock has a 50 day moving average price of $63.79 and a 200-day moving average price of $60.39. The stock has a market capitalization of $1.70 billion, a price-to-earnings ratio of 34.19 and a beta of 0.62.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Tuesday, July 18th. The business services provider reported $0.51 EPS for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.10. The business had revenue of $84.10 million for the quarter, compared to analysts’ expectations of $79.30 million. Exponent had a net margin of 15.94% and a return on equity of 16.52%. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.38 earnings per share. Equities research analysts anticipate that Exponent will post $1.97 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 22nd. Shareholders of record on Friday, September 1st will be given a dividend of $0.21 per share. The ex-dividend date is Wednesday, August 30th. This represents a $0.84 dividend on an annualized basis and a yield of 1.27%. Exponent’s dividend payout ratio (DPR) is currently 43.52%.

In other Exponent news, insider Harri Kytomaa sold 12,000 shares of the company’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $66.38, for a total transaction of $796,560.00. Following the sale, the insider now owns 11,360 shares of the company’s stock, valued at $754,076.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Paul R. Johnston sold 5,000 shares of the company’s stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $65.94, for a total transaction of $329,700.00. Following the sale, the chief executive officer now directly owns 66,335 shares in the company, valued at approximately $4,374,129.90. The disclosure for this sale can be found here. Insiders have sold 51,855 shares of company stock worth $3,392,502 in the last ninety days. Insiders own 2.80% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This report was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at

About Exponent

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.